Filing Flows › Biomerica (BMRA) › R&D spending
Biomerica (BMRA) R&D spending by quarter
Biomerica's R&D spending was $206K in Q1 FY27 (first quarter fiscal 2027), +0.5% from Q4 FY26. Over the last 7 quarters it ranged from $178K (Q3 FY26) to $252K (Q4 FY25).
| Quarter | R&D spending | Q/Q | Y/Y |
|---|---|---|---|
| Q1 FY27 | $206K | +0.5% | -3% |
| Q4 FY26 | $205K | +15% | -19% |
| Q3 FY26 | $178K | -8% | -18% |
| Q2 FY26 | $193K | -9% | — |
| Q1 FY26 | $212K | -16% | — |
| Q4 FY25 | $252K | +16% | — |
| Q3 FY25 | $217K | — | — |
Q1 FY27 at a glance
Biomerica, Q1 FY27: revenue $1.3M (-8% year over year), operating margin -97.0%, net loss $1.2M, operating cash flow −$802K. The chart follows the revenue to costs, profit and cash.
Questions
What is Biomerica's R&D spending?
Biomerica's R&D spending was $206K in Q1 FY27 (first quarter fiscal 2027), +0.5% from Q4 FY26.
How has Biomerica's R&D spending changed?
Over the last 7 quarters it ranged from $178K (Q3 FY26) to $252K (Q4 FY25).